Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
33 - Once a journal ad is PAAB approved, are we required to resubmit the approved JA for PAAB approval if the only change that will be made is to the dimension of the JA (eg, from standard to tabloid size)?
-
You don't have to resubmit for approval if it is just a size change. We do like you to send us a note informing us of the new format for our record. If you change wording or move things around it should be resubmitted for approval. If you shrink the size, remember the minimum type size requirements.
